A problem in the Journal’s editorial offices caused an error of omission to occur in the reporting of competing interests for the February editorial “Defining the Boundaries of Childhood Bipolar Disorder” (Am J Psychiatry 2007; 164:185–188). The disclosure statement should have run as follows:
Dr. Martin reports no competing interests. Dr. Ghaemi currently receives research grants from GlaxoSmithKline and Pfizer; in the past year, he has been on the speakers’ bureaus of Abbott Laboratories, AstraZeneca, and GlaxoSmithKline; and in previous years has served on the advisory boards of Abbott Laboratories, GlaxoSmithKline, Janssen, and Pfizer. Neither he nor his family hold equity positions in pharmaceutical corporations. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships.
Dr. Ghaemi had submitted his disclosure prior to publication, as required by Journal editorial policy.